Survey reveals 83% of life science companies fail to track real-time data 

Since South African scientists successfully sequenced the Omicron variant on November 19, the variant – also known as B.1.1.529 – has now been identified internationally. Tracking cases and speeding up booster jabs is critical, but a survey by Solace of 840 IT professionals revealed that only 17% of life science and healthcare companies have succeeded in implementing real-time data.  

Further research has revealed that 87% of life science companies are facing operational challenges from a lack of investment in data movement. This sets them back, as they resort to making decisions with outdated information, hindering vaccine development and rollout. 

Jamil Ahmed, Distinguished Engineer at Solace, commented: “The health space must implement technologies to allow multiple digital systems to talk to each other in real time, including supply chain, product lifecycle management, quality control, manufacturing and others.”

Image credit: Gerd Altmann

Suggested Reading

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free